Corporate Governance25 Sept 2026, 03:11 pm
Windlas Biotech Closes Trading Window for Q2 FY27 Results
AI Summary
Windlas Biotech Ltd has announced the closure of its trading window for the company's securities. This closure will be effective from October 1, 2026, and will remain in effect until 48 hours after the unaudited financial results for the quarter and half-year ended September 30, 2026, are made public. This measure is in accordance with the company's internal code of conduct for trading.
Key Highlights
- Trading window closure effective October 1, 2026.
- Closure lasts until 48 hours post Q2 FY27 results announcement.
- Adheres to company's insider trading code of conduct.
- Affects trading of company securities.
Price Impact
More from WINDLAS